Based in Lausanne, Switzerland, NewBiologix SA is a technology innovation company developing a proprietary and breakthrough DNA integration platform for the advanced engineering of human and mammalian cell lines for the improved production of viral vectors used in gene therapies.
Location: Switzerland, Vaud, Épalinges
Employees: 11-50
Total raised: $50.3M
Founded date: 2023
Funding Rounds 1
| Date | Series | Amount | Investors |
| 11.05.2023 | Series A | $50.3M | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 11.05.2023 | NewBiologix launches with $50M to make gene therapies more v... | NewBiologix SA emerged from stealth today as a technology innovation company developing a propriet... | startuptic... |
| 11.05.2023 | NewBiologix Raises $50M in Series A Funding | NewBiologix, a Lausanne, Switzerland-based technology company developing a proprietary platform focu... | finsmes.co... |
| - | NewBiologix | “Engineered cell line technology that produces safe and effective AAV drugs for gene therapy, making... | fastfounde... |